Chargement en cours...
Inhaled corticosteroids with combination inhaled long‐acting beta(2)‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
BACKGROUND: Management of chronic obstructive pulmonary disease (COPD) commonly involves long‐acting bronchodilators including beta‐agonists (LABA) and muscarinic antagonists (LAMA). In individuals with persistent symptoms or frequent exacerbations, inhaled corticosteroids (ICS) are also used. LABA...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2016
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464947/ https://ncbi.nlm.nih.gov/pubmed/27830584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011600.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|